Bromocriptine Mesylate Tablet
Product Images NDC 0781-5325

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 0781-5325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 01

Image 01
Chemical structure of Bromocriptine mesylate, showing its molecular composition and connectivity with a molecular weight of 750.72 g/mol as indicated.*
FDA Label Image

Image 02

Image 02
Bromocriptine Mesylate Tablets, USP 2.5 mg oral tablets, packaged in a container of 30 tablets. The label indicates this is a prescription drug by Sandoz Inc, with manufacturing attributed to Lek Pharmaceuticals d.d. in Slovenia for Sandoz Inc, Princeton, NJ. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.